Abstract
Autophosphorylation of kinases influences their conformational state and can also regulate enzymatic activity. Recently, this has become an area of interest for drug discovery. Using Alk2 as an example, we present two protocols — one based on phosphate-binding Alphascreen beads, the other on coupled luminescence measurements of ADP formation — that can be used to screen for inhibitors of autophosphorylation.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Klumpp M, Boettcher A, Becker D, Meder G, Blank J, Leder L, Forstner M, Ottl J, Mayr LM (2006) Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format. J Biomol Screen 11(6):617–633. doi:10.1177/108705106288444
Drueckes P (2016) Protein kinase selectivity profiling using microfluidic mobility shift assays. In: Janzen WP (ed) High throughput screening: methods and protocols, 3rd edn. Methods Mol Biol 1439
Cohen P, Alessi DR (2013) Kinase drug discovery—what’s next in the field? ACS Chem Biol 8(1):96–104. doi:10.1021/cb300610s
Newbatt Y, Hardcastle A, McAndrew PC, Strover JA, Mirza A, Morgan GJ, Burke R, Davies FE, Collins I, van Montfort RL (2013) Identification of autophosphorylation inhibitors of the inositol-requiring enzyme 1 alpha (IRE1alpha) by high-throughput screening using a DELFIA assay. J Biomol Screen 18(3):298–308. doi:10.1177/1087057112465647
Liu Z, Galemmo RA Jr, Fraser KB, Moehle MS, Sen S, Volpicelli-Daley LA, DeLucas LJ, Ross LJ, Valiyaveettil J, Moukha-Chafiq O, Pathak AK, Ananthan S, Kezar H, White EL, Gupta V, Maddry JA, Suto MJ, West AB (2014) Unique functional and structural properties of the LRRK2 ATP-binding pocket. J Biol Chem 289:32937–32951. doi:10.1074/jbc.M114.602318
Wang JH, Stull JT, Huang TS, Krebs EG (1976) A study on the autoactivation of rabbit muscle phosphorylase kinase. J Biol Chem 251(15):4521–4527
Nakayama GR, Parandoosh Z (1999) An immunoassay for assessment of receptor tyrosine kinase autophosphorylation. J Immunol Methods 225(1–2):67–74
Deacon SW, Beeser A, Fukui JA, Rennefahrt UE, Myers C, Chernoff J, Peterson JR (2008) An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 15(4):322–331. doi:10.1016/j.chembiol.2008.03.005
Fabbro D, Cowan-Jacob SW, Mobitz H, Martiny-Baron G (2012) Targeting cancer with small-molecular-weight kinase inhibitors. Methods Mol Biol 795:1–34. doi:10.1007/978-1-61779-337-0_1
Ohmi N, Wingfield JM, Yazawa H, Inagaki O (2000) Development of a homogeneous time-resolved fluorescence assay for high throughput screening to identify Lck inhibitors: comparison with scintillation proximity assay and streptavidin-coated plate assay. J Biomol Screen 5(6):463–470
Zimmerman CM, Mathews LS (1996) Activin receptors: cellular signalling by receptor serine kinases. Biochem Soc Symp 62:25–38
Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massague J (2001) The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. Mol Cell 8(3):671–682
Eglen RM, Reisine T, Roby P, Rouleau N, Illy C, Bosse R, Bielefeld M (2008) The use of AlphaScreen technology in HTS: current status. Curr Chem Genomics 1:2–10. doi:10.2174/1875397300801010002
Pope AJ (1999) Introduction LANCEtrade mark vs. HTRF(R) technologies (or vice versa). J Biomol Screen 4(6):301–302
Seethala R (2000) Fluorescence polarization competition immunoassay for tyrosine kinases. Methods 22(1):61–70. doi:10.1006/meth.2000.1037
Delom F, Chevet E (2006) Phosphoprotein analysis: from proteins to proteomes. Proteome Sci 4:15. doi:10.1186/1477-5956-4-15
Fernando SA, Wilson GS (1992) Studies of the ‘hook’ effect in the one-step sandwich immunoassay. J Immunol Methods 151(1–2):47–66
Briggs GE, Haldane JB (1925) A note on the kinetics of enzyme action. Biochem J 19(2):338–339
Hong CC, Yu PB (2009) Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev 20(5–6):409–418. doi:10.1016/j.cytogfr.2009.10.021
Chen YG, Liu F, Massague J (1997) Mechanism of TGFbeta receptor inhibition by FKBP12. EMBO J 16(13):3866–3876. doi:10.1093/emboj/16.13.3866
Zegzouti H, Zdanovskaia M, Hsiao K, Goueli SA (2009) ADP-Glo: a bioluminescent and homogeneous ADP monitoring assay for kinases. Assay Drug Dev Technol 7(6):560–572. doi:10.1089/adt.2009.0222
Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL (1998) Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273(40):25628–25636
Huse M, Chen YG, Massague J, Kuriyan J (1999) Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 96(3):425–436
Leder L (2015) Site-specific protein labeling in the pharmaceutical industry: experiences from novartis drug discovery. Methods Mol Biol 1266:7–27. doi:10.1007/978-1-4939-2272-7_2
Bouchecareilh M, Caruso ME, Roby P, Parent S, Rouleau N, Taouji S, Pluquet O, Bosse R, Moenner M, Chevet E (2010) AlphaScreen-based characterization of the bifunctional kinase/RNase IRE1alpha: a novel and atypical drug target. J Biomol Screen 15(4):406–417. doi:10.1177/1087057110363823
Huse M, Kuriyan J (2002) The conformational plasticity of protein kinases. Cell 109(3):275–282
Iwasaki Y, Nishiyama H, Suzuki K, Koizumi S (1997) Sequential cis/trans autophosphorylation in TrkB tyrosine kinase. Biochemistry 36(9):2694–2700. doi:10.1021/bi962057x
Schwarz JK, Lovly CM, Piwnica-Worms H (2003) Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol Cancer Res 1(8):598–609
Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67–73
Senisterra G, Chau I, Vedadi M (2012) Thermal denaturation assays in chemical biology. Assay Drug Dev Technol 10(2):128–136. doi:10.1089/adt.2011.0390
Acknowledgments
We highly appreciate the supply of recombinant Alk2 and its substrate Smad1-MH2 by Sonia Faut and Myriam Duckely as well as protein characterization through LC-MS by Peggy Lefeuvre and Francis Bitsch. The support from Geoffrey Cutler in implementing the miniaturized ADP formation assay on an automated screening system was also very helpful. The whole Alk2 project team is acknowledged for input and stimulating discussions. Last but not least, we would like to thank Joerg Trappe for suggesting and encouraging the drafting of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Heedmann, B., Klumpp, M. (2016). Screening for Inhibitors of Kinase Autophosphorylation. In: Janzen, W. (eds) High Throughput Screening. Methods in Molecular Biology, vol 1439. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3673-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3673-1_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3671-7
Online ISBN: 978-1-4939-3673-1
eBook Packages: Springer Protocols